Viewing Study NCT04984733

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-02-26 @ 11:04 AM
Study NCT ID: NCT04984733
Status: RECRUITING
Last Update Posted: 2023-11-29
First Post: 2021-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
Sponsor: University of Southampton
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma - GEJ View
None Cancer of Esophagus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None Oesophagogastric View
None Oesophagogastric adenocarcinoma, View
None MGMT deficient, View
None O6-methylguanine-DNA-methyltransferase View
None MGMT protein, human View
None MGMT methylated View